| ||
Pharmaceutical industry would grow at 19% in 2013: Morgan Stanley Economic Times Based on this, the company has given Overweight ( Buy ) and Equalweight (Hold) ratings to the large pharmaceutical stocks. According to the report, long term strategies appear better for Sun Pharma, Lupin and Dr Reddy's Lab. Cipla and Ranbaxy will need ... See all stories on this topic » | ||
| ||
| ||
Clinical Site Services Expands Local Enrollment Specialist(TM) Service ... eReleases (press release) With over 11 years of experience working within a clinical research environment in the pharmaceutical/biotech industry, Ms. DeHaemer comes to CSS with an extensive background in understanding the enrollment needs of sites, sponsors and CROs. See all stories on this topic » | ||
Hikma to buy Egyptian pharma company for around $20 million The Pharma Letter Fast-growing Jordan-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says it has agreed to acquire the Egyptian Company for Pharmaceuticals & Chemical Industries (EPCI) from a consortium of shareholders. Hikma will pay an aggregate cash ... See all stories on this topic » | ||
Global pharmaceutical regulatory affairs specialist ELC Group hosts ... PharmiWeb.com (press release) Cambridge, UK, 10th January 2013 – ELC GROUP, one of the fastest-growing providers of regulatory affairs consulting services, today announces that it will be hosting a two-day international training seminar from 28th February – 1st March 2013 in Mumbai ... See all stories on this topic » | ||
Raptor Pharmaceutical Corp. Reports First Quarter Fiscal Year 2013 Financial ... PharmaLive (press release) (subscription) 9, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today reported financial results for its first fiscal quarter ended November 30, 2012. Financial Results and Other Recent Highlights • Net loss for the ... See all stories on this topic » | ||
Russian government may stop foreign drugmakers from state tendering The Pharma Letter The new measure also aims to encourage major global pharmaceutical producers to localize their production in Russia. The Russian government believes that the new measure will allow it to reduce the share of imported drugs in the total procurements, ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment